News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,739 Results
Type
Article (31266)
Company Profile (52)
Press Release (354421)
Section
Business (112379)
Career Advice (1307)
Deals (23983)
Drug Delivery (81)
Drug Development (59377)
Employer Resources (100)
FDA (9800)
Job Trends (9047)
News (210487)
Policy (25407)
Tag
Academia (1826)
Africa (564)
Alliances (41958)
Alzheimer's disease (925)
Antibody-drug conjugate (ADC) (41)
Approvals (9733)
Arizona (59)
Artificial intelligence (51)
Asia (25221)
Australia (4533)
Bankruptcy (227)
Best Places to Work (7425)
Biosimilars (44)
Breast cancer (39)
C2C Services and Suppliers (31455)
California (1098)
Canada (556)
Cancer (371)
Career advice (1095)
Cell therapy (94)
China (106)
Clinical research (46237)
Collaboration (116)
Colorado (43)
Compensation (62)
COVID-19 (2386)
Cystic fibrosis (44)
Data (231)
Diabetes (64)
Diagnostics (3326)
Drug pricing (62)
Earnings (38656)
Employer resources (89)
Europe (60372)
Events (43795)
Executive appointments (65)
FDA (9954)
Florida (152)
Funding (89)
Gene therapy (79)
GLP-1 (506)
Government (3982)
Healthcare (11339)
Hotbed/Location (250592)
Illinois (124)
Indiana (89)
Infectious disease (2418)
Inflammatory bowel disease (59)
Interviews (227)
IPO (10256)
Job creations (1742)
Job search strategy (951)
Kansas (55)
Layoffs (239)
Legal (6970)
Liver cancer (39)
Lung cancer (81)
Manufacturing (78)
Maryland (283)
Massachusetts (808)
Medical device (5799)
Medtech (5800)
Mergers & acquisitions (13655)
Metabolic disorders (230)
Michigan (53)
Minnesota (64)
Neuroscience (1037)
New Jersey (347)
New York (392)
NextGen Class of 2024 (3646)
Non-profit (2749)
North Carolina (273)
Northern California (522)
Obesity (142)
Ohio (59)
Opinion (164)
Patents (54)
Pennsylvania (318)
People (24182)
Phase I (13902)
Phase II (20069)
Phase III (16333)
Pipeline (85)
Policy (50)
Postmarket research (1834)
Preclinical (5775)
Rare diseases (90)
Real estate (2566)
Recruiting (41)
Regulatory (15309)
Research institute (1585)
Resumes & cover letters (194)
South America (789)
Southern California (452)
Startups (1875)
Texas (122)
United States (4709)
Vaccines (511)
Washington State (139)
Weight loss (138)
Date
Today (60)
Last 7 days (435)
Last 30 days (1480)
Last 365 days (23646)
2024 (16586)
2023 (25265)
2022 (33395)
2021 (35894)
2020 (34075)
2019 (27911)
2018 (21235)
2017 (20189)
2016 (18692)
2015 (21494)
2014 (15948)
2013 (12877)
2012 (13623)
2011 (14401)
2010 (13078)
385,739 Results for "biofrontera ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
Biofrontera Inc. today announced the restructuring of agreements between the Company and its former parent company Biofrontera AG.
February 20, 2024
·
5 min read
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Business
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatologic products, reported financial results for the three months ended March 31, 2024 and provided a business update.
May 15, 2024
·
11 min read
Business
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024.
May 6, 2024
·
1 min read
Business
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
Biofrontera, Inc. today reported financial results for the three and twelve months ended December 31, 2023.
March 15, 2024
·
14 min read
Press Releases
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 15, 2024
·
10 min read
Business
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Inc. (NASDAQ:BFRI) today announced it has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors.
February 20, 2024
·
7 min read
Genetown
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Inc. announced that it has closed on a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors as of February 22, 2024.
February 23, 2024
·
7 min read
Business
Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
August 9, 2024
·
1 min read
Genetown
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
Biofrontera, Inc. announced that its 2024 Annual Meeting of Stockholders will be held on June 12, 2024 and that the close of business on April 22, 2024 will be the record date for the determination of stockholders entitled to notice of and to vote at the 2024 Annual Meeting.
March 26, 2024
·
5 min read
1 of 38,574
Next
